modernghana logo

FEATURED: This Man Is Not A Genuine Servant Of Ya’oh, My Dear Paa Kow!!...

body-container-line
August 30, 2018 | Feature Article

Rockefeller’s Man-Made AIDS Syndrome

Rockefeller’s Man-Made AIDS Syndrome

HIV/Aids-related skin condition
There is plenty of evidence to suggest AIDS was requested, created and distributed by Rockefeller-linked individuals and organizations.

For example, there was the “Department of Defense Appropriations Hearings” in 1970. During this hearing, a 1969 document is discussed outlining how the National Academy of Sciences-National Research Council NAS-NRC, advised the US military to develop synthetic biological agents against which no cure can be developed in order to depopulate the world.

Those viruses, in fact, were already developed a long time before and are functionally identical to HIV/AIDS.

The NAS-NRC was headed by Frederick Seitz at the time, also then President of Rockefeller University. The real smoking gun is the 1977 Pfizer contract for; “Large-Scale Tissue Culture Virus Production for Cancer Research.”

It’s hard to imagine what they meant by “large-scale,” as Pfizer was already making “over 28,000 liters of virus harvest fluids”, a mix of viruses now linked to the AIDS virus. Pfizer’s head at the time was Edmund T. Pratt, director of Rockefeller’s Chase Manhattan Bank and member of Rockefeller’s Council on Foreign Relations.

Pfizer’s partner in this project was Rockefeller’s International Agency for Research in Cancer, the IARC. Pfizer has offices in New York City, and the IARC has offices in Uganda. AIDS first sprung up in NYC and Uganda at about the same time.

Another Pfizer director linked to Rockefeller’s cancer industry is Paul A. Marks, chief officer at Sloan Kettering Memorial Cancer Center, director of treatment regimens at the National Cancer Institute (NCI) and director of the American Association for Cancer Research.

Rockefeller’s AIDS Liason Litton Bionetics

Litton Bionetics, a division of mammoth defense contractor Litton Industries, is linked to the Rockefeller empire through a history of managerial appointments.

A Litton Bionetics report to the NCI in 1971 listed virtually every virus, viral recombinant, and infectious agent under study by the world’s leading cancer researchers, vaccine developers, and biological weapons contractors.

While the document does not mention West Nile Virus, it does mention a “Dawson’s encephalitis” virus, likely deriving its name not from the West Nile district of Uganda, but from a Rockefeller-linked cancer investigator by the name of Dawson who was clearly affiliated, by NCI contract, with Litton and the IARC laboratory.

Contracts between Litton Bionetics and the US government, printed in a book called the “Special Virus Cancer Program”, military jargon for “Secret Cancer Virus Program”, describe a search for a “human cancer virus” going back to 1962.

Contracts describe the scientists' attempts at “co-cultivation” and “hybridization”, mixing leukemia, lymphoma, sarcoma, and Epstein-Barr virus particles to create or “rescue” or “isolate” new mutant strains of viruses.

Other documents show Dr. Robert Gallo of the National Cancer Institute working under contract with Litton Bionetics to create viruses that were functionally identical to HIV. Gallo, a well known medical despote, would later claim to have “discovered” AIDS. “Invented” is more accurate but less glamorous.

Northop Grumman Corporation, whose head, Kent Kresa, is also on Rockefellers Council on Foreign Relations, has since bought Litton.

Another Rockefeller’s medical criminal company Merck

Any method which appears to offer advantages to a nation at war will be vigorously employed by that nation. There is but one logical course to pursue, namely, to study the possibilities of such warfare from every angle …” as stated by George W. Merck, Merck Pharmaceutical Company President, in his report on biological warfare to U.S. Secretary of War, 1942.

Merck’s ties to Rockefeller are numerous, involving money from the Rockefeller and Sloan foundations, not to mention officials from I.G. Farben. Henry Kissinger, a long-time member of Rockefeller’s Council on Foreign Relations, remains on Merck’s board of advisors.

Merck’s ties to American biological warfare research goes back to its very beginnings. In 1941, Secretary of War Henry L. Stimson, a member of Rockefeller’s Council on Foreign Relations, requested the Rockefeller-controlled National Academy of Sciences (NAS) to appoint a committee to survey the feasibility of biological war weapons.

The 1942 NAS committee concluded that biological war might be feasible and recommended that steps be taken to reduce U.S. vulnerability to a bio-weapon attack. A civilian agency, the War Reserve Service was formed under the direction of George W. Merck, of the Merck Company.

George Merck made it clear that “All possible living agents, or their toxic products, which were pathological for man, animal and plants were considered.” Merck mentions significant advances in “human immunity” biological warfare weapons as early as 1946.

Records show the Merck pharmaceutical company received a major share of the Nazi “flight capital”, the working capital of the IG Farben Rockefeller chemical cartel, at the close of World War II.

These facts were revealed by Norman Covert, Army public relations director at Fort Detrick in Frederick, MD, the same “Camp Detrick” given to George Merck to use for his wartime research. Camp Detrick Army Chemical Corps worked with Germany’s bio-warfare specialist Major General Kurt Blome, just two months after he was acquitted at Nuremberg.

Bayer worked at Ft. Detrick after WW2, developing “new weapons.” No doubt Merck put all that Nazi know-how to work making war viruses. A “Special Virus Cancer Program” contract from 1971 revealed Merck developed “methods of propagation, purification, concentration, and specific quantitation of candidate viruses suspected or shown to cause cancer in man.”

One of the viruses mentioned in the contract was called the “KT strain of feline leukemia”, what leading experts have identified as a man-made virus, possibly a “cat/human mutant.” At the onset of the AIDS epidemic, the Center for Disease Control hepatitis B Chief Dr. Don Francis said;

“Combine these two diseases, feline leukemia, and hepatitis,

and you have the immune deficiency.”
Merck also created a Hepatitis B vaccine that they tested on New York homosexuals, their “Phase I and II studies” occurring between 1976 and 1977 which could account for the first recorded New York AIDS cases in Manhattan in 1978. One last interesting connection. George Merck lived on Jupiter Island, Florida, home to Paul Mellon (Andrew’s son) and Prescott Bush.

Rockefeller’s man-made AIDS syndrome
Merck began AIDS drug research in 1986, yielding two medicines. There are more potential HIV/AIDS therapies in their “pipeline,” including an investigational vaccine.

The International AIDS Vaccine Initiative (IAVI) is a global organization working to speed the development and distribution of preventive AIDS vaccines. Its “President and Founder” is Dr. Seth Berkley.

Prior to founding the initiative, Dr. Berkley was Associate Director of the Health Sciences Division at The Rockefeller Foundation. Born in January 1996, the organization has four strategies.

Four quotes

  • To create global demand for a vaccine to get the drive for an AIDS vaccine back onto all agendas, whether political, media, scientific or whatever.

  • To create an aggressive applied science program to help move ideas from the research stage into accelerated clinical testing it is critical that we ensure that vaccines are tested in humans.

  • To try to create a better environment for industrial investment in AIDS vaccines to drive the creation of incentives for industry.

  • To ensure global access to ensure that, when a vaccine is made, the systems are in place to have simultaneous availability in the north and south, which of course has never been done for any vaccine.

IAVI is now capitalized at slightly more than a quarter of a billion dollars. The Bill & Melinda Gates Foundation has contributed $126.5 million.

Vaccine making is big bucks these days. Thirteen days after 9-11, the Pentagon announced plans to develop fifteen new vaccines at a cost of $3.2 billion over twelve years.

The Defense Department determined it needs not only a new anthrax vaccine but also at least thirteen other new vaccines, including serum for smallpox, next-generation anthrax, the plague, three varieties of equine encephalitis, Coxiella burnetii, Tularemia, botulinum toxin, staphlococcyl enterotoxin b, ricin, and Brucella.

The project would nearly double the number of vaccines available in the world. Just 20 vaccines are commercially available. Merck Pharmaceuticals, the largest private producer, manufacturers nine of them.

According to Merck’s website, Merck’s “approach to business,” it’s “fundamental value system” that helps “translate how we spend our research dollars” is driven by a statement from a 1950 speech in which George W. Merck stated that “medicine is for the people, not for the profits. If we remember that the profits will follow.”

Profits follow even more when you forget about the people, as Merck’s various million-dollar virus “make-work-projects” proves.

Bayer’s latest chemical and biological weapons

The Cutter Drug Company, located in Berkeley, California since 1903, began making smallpox vaccines way back in 1906, and the plague in 1944. They’ve been making the plague ever since, 2.6 million doses every year, a $1.7 million dollar contract. Cutter makes about $10 million per year in military bio-weapons contracts. In 1958, Cutter was sued over crippling two children with the Salk polio vaccine.

Bayer acquired Cutter’s Berkeley laboratory in 1974. In 1978, Bayer bought Miles Inc., makers of Alka-Seltzer, One-a-Day Vitamins and Bactine. Today, this lab is known as “Miles Cutter.” Federal inspectors from Rockville, Maryland, did a routine inspection of Miles Cutter’s plague vaccine “on the assumption that [it]would be used in the Gulf War.”

Editorial
Interestingly, many biologists believe that there is; “no feasible defense against biological attack” because “the variety of attack agents is too large.” If vaccines are useless for defense, why are they being made? Well, what other “weapon of mass destruction” can you grow in a petri dish?

As weapons of mass destruction go, they’re the biggest bang for your war-profiteering buck. Weapon? Yes, weapon. To make a vaccine, you must first make the pathogen the vaccine will guard against.

To make lots of smallpox vaccine, you have to make lots of smallpox. Bayer is essentially making useless defensive vaccines so it can get away with selling very effective offensive viruses while not (technically) running afoul of international bio-war treaties.

Bayer is also still in the poison gas business. After the Gulf War, the UN imposed far-reaching sanctions against Iraq, especially concerning getting rid of weapons of mass destruction.

It has now come out that 200 tons of a basic chemical substance for the neurotoxin VX have disappeared from Iraq’s armaments. The patent for the chemical warfare agent VX comes from Bayer.

Johan van Dongen
Johan van Dongen

Johan Van Dongen is a man who cares about humanity. As a scientist, he believes the scientific world is on the wrong track when it comes to the secret of using human beings for experiments and for testing bio-weapons.

Disclaimer: "The views/contents expressed in this article are the sole responsibility of Johan van Dongen and do not neccessarily reflect those of Modern Ghana. Modern Ghana will not be responsible or liable for any inaccurate or incorrect statements contained in this article."

Opinions Feature Article

Author: Johan van Dongen
Stories: 143 Publication(s)
Column: JohanvanDongen

quot-img-1The secret to success in life is to overcome fear

By: Paul Doku quot-img-1
body-container-line